The role of chondroitin sulfate proteoglycan 4 (CSPG4) in the induction of multidruQ tolerance in melanoma cells (NO Forschung und Bildung funding led by Karl Landsteiner Uni for Med Sci) (2016–2019)

Grant type:
Karl Landsteiner University of Health Sciences
Researchers:
Funded by:
Karl Landsteiner University of Health Sciences